Curi RMB Capital LLC Acquires 1,941 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Curi RMB Capital LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 88,967 shares of the healthcare conglomerate's stock after purchasing an additional 1,941 shares during the period. UnitedHealth Group comprises about 1.0% of Curi RMB Capital LLC's investment portfolio, making the stock its 19th largest position. Curi RMB Capital LLC's holdings in UnitedHealth Group were worth $45,005,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth about $25,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $30,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth about $30,000. Finally, Promus Capital LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $32,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH traded up $4.72 during mid-day trading on Wednesday, hitting $431.90. The stock had a trading volume of 4,515,816 shares, compared to its average volume of 4,422,264. The company's fifty day simple moving average is $508.83 and its two-hundred day simple moving average is $537.99. UnitedHealth Group Incorporated has a fifty-two week low of $417.12 and a fifty-two week high of $630.73. The company has a market cap of $395.06 billion, a PE ratio of 27.86, a PEG ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the company earned $6.91 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.94%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is 35.18%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on UNH shares. Oppenheimer reduced their price target on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating for the company in a research report on Monday. Mizuho upped their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. KeyCorp reduced their target price on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating for the company in a report on Monday. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday. Finally, Piper Sandler decreased their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Three research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $604.67.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.